Duncan MacCannell

Prof. Duncan MacCannell

CDC

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Cell
Verified
Journal Article
Closed access
NWNicole L. Washington
Nicole L. Washington
KGKarthik Gangavarapu
Karthik Gangavarapu
MZMark Zeller
Mark Zeller
ABAlexandre Bolze
Alexandre Bolze
ECElizabeth T. Cirulli
Elizabeth T. Cirulli
KAKristian G. Andersen
Kristian G. Andersen

31 July 2020 in Science
Verified
Journal Article
Open access
PDF file
XDXianding Deng
Xianding Deng
WGWei Gu
Wei Gu
SFScot Federman
Scot Federman
LPLouis du Plessis
Louis du Plessis
OPOliver G. Pybus
Oliver G. Pybus
CCCharles Y. Chiu
Charles Y. Chiu
Epidemic in Northern California: Genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks is valuable for tracing the sources and perhaps for drawing lessons about preventing future outbreaks. Genomic analysis by Deng et al. revealed that Northern California experienced a complex series of introductions of the virus, deriving not only from state-to-state transmission but also from international travel by air and ship. The study highlights the importance of being able to rapidly test and trace contacts of positive cases to enable swift control. Science , this issue p. 582

30 October 2020 in Science
Verified
Journal Article
Open access
PDF file
TBTrevor Bedford
Trevor Bedford
AGAlexander L. Greninger
Alexander L. Greninger
PRPavitra Roychoudhury
Pavitra Roychoudhury
LSLea M. Starita
Lea M. Starita
MFMichael Famulare
Michael Famulare
MSMonica L. Zigman Suchsland
Monica L. Zigman Suchsland
A series of unfortunate events: The history of how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread around the planet has been far from clear. Several narratives have been propagated by social media and, in some cases, national policies were forged in response. Now that many thousands of virus sequences are available, two studies analyzed some of the key early events in the spread of SARS-CoV-2. Bedford et al. found that the virus arrived in Washington state in late January or early February. The viral genome from the first case detected had mutations similar to those found in Chinese samples and rapidly spread and dominated subsequent undetected community transmission. The other viruses detected had origins in Europe. Worobey et al. found that early introductions into Germany and the west coast of the United States were extinguished by vigorous public health efforts, but these successes were largely unrecognized. Unfortunately, several major travel events occurred in February, including repatriations from China, with lax public health follow-up. Serial, independent introductions triggered the major outbreaks in the United States and Europe that still hold us in the grip of control measures. Science , this issue p. 571 , p. 564

1 May 2021 in Cell
Verified
Journal Article
Closed access
TATara Alpert
Tara Alpert
ABAnderson F. Brito
Anderson F. Brito
ELErica Lasek-Nesselquist
Erica Lasek-Nesselquist
JRJessica Rothman
Jessica Rothman
AVAndrew L. Valesano
Andrew L. Valesano
NGNathan D. Grubaugh
Nathan D. Grubaugh

11 June 2020 in Nature Medicine
Verified
Journal Article
Open access
PDF file
ABAllison Black
Allison Black
DMDuncan MacCannell
Duncan MacCannell
TSThomas R. Sibley
Thomas R. Sibley
TBTrevor Bedford
Trevor Bedford
Increasingly, public-health agencies are using pathogen genomic sequence data to support surveillance and epidemiological investigations. As access to whole-genome sequencing has grown, greater amounts of molecular data have helped improve the ability to detect and track outbreaks of diseases such as COVID-19, investigate transmission chains and explore large-scale population dynamics, such as the spread of antibiotic resistance. However, the wide adoption of whole-genome sequencing also poses new challenges for public-health agencies that must adapt to support a new set of expertise, which means that the capacity to perform genomic data assembly and analysis has not expanded as widely as the adoption of sequencing itself. In this Perspective, we make recommendations for developing an accessible, unified informatic ecosystem to support pathogen genomic analysis in public-health agencies across income settings. We hope that the creation of this ecosystem will allow agencies to effectively and efficiently share data, workflows and analyses and thereby increase the reproducibility, accessibility and auditability of pathogen genomic analysis while also supporting agency autonomy.

16 February 2022 in GigaScience
Verified
Journal Article
Open access
PDF file
EGEmma J Griffiths
Emma J Griffiths
RTRuth Timme
Ruth Timme
CMCatarina Inês Mendes
Catarina Inês Mendes
APAndrew Page
Andrew Page
NANabil-Fareed Alikhan
Nabil-Fareed Alikhan
DMDuncan MacCannell
Duncan MacCannell
Background: The Public Health Alliance for Genomic Epidemiology (PHA4GE) (https://pha4ge.org) is a global coalition that is actively working to establish consensus standards, document and share best practices, improve the availability of critical bioinformatics tools and resources, and advocate for greater openness, interoperability, accessibility, and reproducibility in public health microbial bioinformatics. In the face of the current pandemic, PHA4GE has identified a need for a fit-for-purpose, open-source SARS-CoV-2 contextual data standard. Results: As such, we have developed a SARS-CoV-2 contextual data specification package based on harmonizable, publicly available community standards. The specification can be implemented via a collection template, as well as an array of protocols and tools to support both the harmonization and submission of sequence data and contextual information to public biorepositories. Conclusions: Well-structured, rich contextual data add value, promote reuse, and enable aggregation and integration of disparate datasets. Adoption of the proposed standard and practices will better enable interoperability between datasets and systems, improve the consistency and utility of generated data, and ultimately facilitate novel insights and discoveries in SARS-CoV-2 and COVID-19. The package is now supported by the NCBI’s BioSample database.